The Swedish National Board of Health and Welfare (NBHW) recently published new treatment guidelines which completely abandon recommendations that children with gender identity issues undergo so-called “gender-affirming care.”
Sweden’s new treatment guidelines for youth with “gender dysphoria,” which came out last week, say that the first line of treatment should be psychosocial support rather than giving kids dangerous drugs to stop puberty or mutilating their bodies.
“Psychosocial support that helps the young person live with the body’s pubertal development without medication needs to be the first option when choosing care measures,” the new guidelines read.
According to NBHW, “the risks of puberty suppressing treatment with GnRH-analogues and gender-affirming hormonal treatment currently outweigh the possible benefits, and that the treatments should be offered only in exceptional cases.”
“Although the prevalence of detransition is still unknown, the knowledge that it occurs and that gender confirming treatment thus may lead to a deteriorating of health and quality of life (i.e. harm), is important for the overall judgment and recommendation,” the new guidelines explain.
Another factor that played a role in Sweden’s decision to ditch WPATH’s guidelines was the sharp rise in the number of young people with gender dysphoria for no clear reason, especially among teenage girls who had never had gender distress before.link